{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:32:37Z","timestamp":1761744757152},"reference-count":26,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.8771","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T08:26:34Z","timestamp":1526977594000},"source":"Crossref","is-referenced-by-count":1,"title":["In\u00ef\u00bf\u00bdvitro effects of arsenic trioxide, interferon \u03b1 and zidovudine in adult T cell leukemia\/lymphoma cells"],"prefix":"10.3892","author":[{"given":"Miho","family":"Hachiman","sequence":"first","affiliation":[{"name":"Division of Hematology and Immunology, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890\u20118544, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[{"name":"Division of Hematology and Immunology, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890\u20118544, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chibueze","family":"Ezinne","sequence":"additional","affiliation":[{"name":"Division of Hematology and Immunology, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890\u20118544, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Kuroki","sequence":"additional","affiliation":[{"name":"Division of Hematology and Immunology, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890\u20118544, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kozako","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814\u20110180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomichi","family":"Arima","sequence":"additional","affiliation":[{"name":"Division of Hematology and Immunology, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890\u20118544, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"key20200714082915_b1-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20200714082915_b2-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20200714082915_b3-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: A nationwide retrospective study","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"key":"key20200714082915_b4-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.bbmt.2014.02.014","article-title":"High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia","volume":"20","author":"Shigematsu","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"key":"key20200714082915_b5-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: A multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20200714082915_b6-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20200714082915_b7-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/sj.leu.2401742","article-title":"Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia\/lymphoma","volume":"14","author":"Bazarbachi","year":"2000","journal-title":"Leukemia"},{"key":"key20200714082915_b8-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1182\/blood-2009-03-211821","article-title":"Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia\/lymphoma (ATL)","volume":"113","author":"Kchour","year":"2009","journal-title":"Blood"},{"key":"key20200714082915_b9-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1182\/blood-2014-04-572750","article-title":"ATL response to arsenic\/interferon therapy is triggered by SUMO\/PML\/RNF4-dependent Tax degradation","volume":"125","author":"Dassouki","year":"2015","journal-title":"Blood"},{"key":"key20200714082915_b10-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ijc.20007","article-title":"Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells","volume":"109","author":"Takeda","year":"2004","journal-title":"Int J Cancer"},{"key":"key20200714082915_b11-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"key20200714082915_b12-ol-0-0-8771","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/JVI.65.12.6892-6899.1991","article-title":"Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: Evidence for a pretranslational component of regulation","volume":"65","author":"Arima","year":"1991","journal-title":"J Virol"},{"key":"key20200714082915_b13-ol-0-0-8771","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood.V84.9.3080.3080","article-title":"A novel diagnostic method of adult T-cell leukemia: Monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction","volume":"84","author":"Takemoto","year":"1994","journal-title":"Blood"},{"key":"key20200714082915_b14-ol-0-0-8771","first-page":"285","article-title":"A retrovirus from human leukemia cell lines: Its isolation, characterization, and implication in human adult T-cell leukemia (ATL)","volume":"12","author":"Yoshida","year":"1982","journal-title":"Princess Takamatsu Symp"},{"key":"key20200714082915_b15-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1620\/tjem.157.1","article-title":"Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I","volume":"157","author":"Lee","year":"1989","journal-title":"Tohoku J Exp Med"},{"key":"key20200714082915_b16-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/bjc.1980.229","article-title":"Isobologram analysis of the combined effects of anti-tumour platinum complexes and ionizing radiation on mammalian cells","volume":"42","author":"Szumiel","year":"1980","journal-title":"Br J Cancer"},{"key":"key20200714082915_b17-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transpl"},{"key":"key20200714082915_b18-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/17135","article-title":"Molecular characterization of mitochondrial apoptosis-inducing factor","volume":"397","author":"Susin","year":"1999","journal-title":"Nature"},{"key":"key20200714082915_b19-ol-0-0-8771","first-page":"2849","article-title":"Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation","volume":"96","author":"El-Sabban","year":"2000","journal-title":"Blood"},{"key":"key20200714082915_b20-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1074\/jbc.M302637200","article-title":"STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis","volume":"279","author":"Townsend","year":"2004","journal-title":"J Biol Chem"},{"key":"key20200714082915_b21-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1038\/sj.onc.1205426","article-title":"p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3","volume":"21","author":"Lin","year":"2002","journal-title":"Oncogene"},{"key":"key20200714082915_b22-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1038\/sj.onc.1203525","article-title":"Complex roles of Stat1 in regulating gene expression","volume":"19","author":"Ramana","year":"2000","journal-title":"Oncogene"},{"key":"key20200714082915_b23-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-4690-10-52","article-title":"Interferon-alpha (IFN-alpha) suppresses HTLV-1 gene expression and cell cycling, while IFN-alpha combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells","volume":"10","author":"Kinpara","year":"2013","journal-title":"Retrovirology"},{"key":"key20200714082915_b24-ol-0-0-8771","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood.V93.1.278","article-title":"Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells","volume":"93","author":"Bazarbachi","year":"1999","journal-title":"Blood"},{"key":"key20200714082915_b25-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1182\/blood-2002-09-2986","article-title":"Arsenic\/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells","volume":"101","author":"Nasr","year":"2003","journal-title":"Blood"},{"key":"key20200714082915_b26-ol-0-0-8771","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1182\/blood-2006-04-015537","article-title":"Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1","volume":"109","author":"Brown","year":"2007","journal-title":"Blood"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T08:50:14Z","timestamp":1594716614000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.8771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":26,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.8771","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]}}}